Ehab Mahgoub

The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study

Robert J. Moots, Ricardo Machado Xavier, Chi Chiu Mok et al. · PLoS ONE · 2017 · 131 citations · Full text

The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a multinational, multicenter study

Rubén Burgos‐Vargas, James Cheng‐Chung Wei, Mahboob U. Rahman et al. · Arthritis Research & Therapy · 2016 · 61 citations · Full text

An epidemiological study to assess the prevalence of diabetic peripheral neuropathic pain among adults with diabetes attending private and institutional outpatient clinics in South Africa

Andrew Jacovides, Mampedi Bogoshi, Larry A. Distiller et al. · Journal of International Medical Research · 2014 · 48 citations · Full text

Manufacturing history of etanercept (Enbrel^®): Consistency of product quality through major process revisions

Brian Hassett, Ena Singh, Ehab Mahgoub et al. · mAbs · 2017 · 37 citations · Full text

Etn Drug Substance, Tumor Necrosis Factor, Pharmaceutical Science +13

Variability of intended copies for etanercept (Enbrel®): Data on multiple batches of seven products

Brian Hassett, Morton Scheinberg, Gilberto Castañeda‐Hernández et al. · mAbs · 2017 · 28 citations · Full text

Release Specifications, Engineering, Immunology +16